442 related articles for article (PubMed ID: 17126746)
1. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma.
Szeimies RM
Dermatol Clin; 2007 Jan; 25(1):89-94. PubMed ID: 17126746
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial.
Surrenti T; De Angelis L; Di Cesare A; Fargnoli MC; Peris K
Eur J Dermatol; 2007; 17(5):412-5. PubMed ID: 17673385
[TBL] [Abstract][Full Text] [Related]
3. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
4. Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma.
Kuijpers DI; Thissen MR; Thissen CA; Neumann MH
J Drugs Dermatol; 2006; 5(7):642-5. PubMed ID: 16865869
[TBL] [Abstract][Full Text] [Related]
5. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.
Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B
Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157
[TBL] [Abstract][Full Text] [Related]
6. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
Farhi D; Bedane C; Savary J; Basset-Seguin N
Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response.
Fantini F; Greco A; Del Giovane C; Cesinaro AM; Venturini M; Zane C; Surrenti T; Peris K; Calzavara-Pinton PG
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):896-901. PubMed ID: 21054566
[TBL] [Abstract][Full Text] [Related]
8. Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers.
Ortiz-Policarpio B; Lui H
Skin Therapy Lett; 2009; 14(6):1-3. PubMed ID: 19609473
[TBL] [Abstract][Full Text] [Related]
9. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate.
Angell-Petersen E; Sørensen R; Warloe T; Soler AM; Moan J; Peng Q; Giercksky KE
J Invest Dermatol; 2006 Feb; 126(2):265-71. PubMed ID: 16374471
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies.
Foley P; Freeman M; Menter A; Siller G; El-Azhary RA; Gebauer K; Lowe NJ; Jarratt MT; Murrell DF; Rich P; Pariser DM; Oseroff AR; Barnetson R; Anderson C; Kossard S; Gibson LE; Tope WD
Int J Dermatol; 2009 Nov; 48(11):1236-45. PubMed ID: 20064185
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy with methyl-5-aminolevulinate for basal cell carcinoma: A systematic review and meta-analysis.
Wang BC; Fu C; Qin L; Zeng XY; Liu Q
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101667. PubMed ID: 31978564
[TBL] [Abstract][Full Text] [Related]
12. Urticaria after methyl aminolevulinate photodynamic therapy in a patient with nevoid basal cell carcinoma syndrome.
Wolfe CM; Green WH; Hatfield HK; Cognetta AB
J Drugs Dermatol; 2012 Nov; 11(11):1364-5. PubMed ID: 23135091
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy.
Gracia-Cazaña T; Mascaraque M; Lucena SR; Vera-Álvarez J; González S; Juarranz Á; Gilaberte Y
PLoS One; 2019; 14(4):e0215537. PubMed ID: 31017970
[TBL] [Abstract][Full Text] [Related]
14. Daylight-mediated photodynamic therapy of basal cell carcinomas - an explorative study.
Wiegell SR; Skødt V; Wulf HC
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):169-75. PubMed ID: 23294223
[TBL] [Abstract][Full Text] [Related]
15. Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers.
Tarstedt M; Gillstedt M; Wennberg Larkö AM; Paoli J
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):420-3. PubMed ID: 26841041
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy for basal cell carcinomas in organ-transplant recipients.
Guleng GE; Helsing P
Clin Exp Dermatol; 2012 Jun; 37(4):367-9. PubMed ID: 22420420
[TBL] [Abstract][Full Text] [Related]
17. Experience and BCC subtypes as determinants of MAL-PDT response: preliminary results of a national Brazilian project.
Ramirez DP; Kurachi C; Inada NM; Moriyama LT; Salvio AG; Vollet Filho JD; Pires L; Buzzá HH; de Andrade CT; Greco C; Bagnato VS
Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):22-6. PubMed ID: 24412582
[TBL] [Abstract][Full Text] [Related]
18. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
Morton CA
Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
[TBL] [Abstract][Full Text] [Related]
19. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.
Szeimies RM; Ibbotson S; Murrell DF; Rubel D; Frambach Y; de Berker D; Dummer R; Kerrouche N; Villemagne H;
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1302-11. PubMed ID: 18624836
[TBL] [Abstract][Full Text] [Related]
20. Giant and large basal cell carcinoma treated with topical photodynamic therapy.
Eibenschutz L; Marenda S; Buccini P; De Simone P; Ferrari A; Mariani G; Silipo V; Catricalà C
Eur J Dermatol; 2008; 18(6):663-6. PubMed ID: 18955200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
